Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Health In TechHIT -0.97%19 Debt-to-Equity is 0.01 as of Jun. 2026, which is at its 10-year median of 0.01. GuruFocus rates HIT with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 2,247 Software companies, Health In Tech ranks better than 99.96% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Health In Tech's Debt-to-Equity or its related term are showing as below:
HIT'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.01 Max: 0.34
Current: 0.01
During the past 4 years, the highest Debt-to-Equity Ratio of Health In Tech was 0.34. The lowest was 0.01. And the median was 0.01.
HIT's Debt-to-Equity is ranked better than 99.96% of 2247
companies
in the Software industry
Industry Median: 0.19
vs HIT: 0.01
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Health In Tech Debt-to-Equity Related Terms
Health In Tech Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Health In Tech's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Software - Application subindustry, Health In Tech's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health In Tech Debt-to-Equity vs Software Industry
For the Software industry and Technology sector, Health In Tech's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Health In Tech's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Health In Tech (HIT) has a Debt-to-Equity of 0.01 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Health In Tech and its competitors. This is near median its historical median of 0.01. Over the past decade, Health In Tech's Debt-to-Equity has ranged from 0.01 to 0.34. According to the industry distribution chart, Health In Tech ranks #1 out of 2247 companies in the Software industry, placing it in the top 0%.
Is Health In Tech's Debt-to-Equity too high?
Health In Tech's current Debt-to-Equity of 0.01 is near median its 10-year median of 0.01. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 0.34. The Software industry median Debt-to-Equity is 0.19. Health In Tech's value of 0.01 is 94.7% below this industry median. Based on the distribution chart, Health In Tech ranks #1 out of 2247 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, Health In Tech has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Health In Tech's Debt-to-Equity compare to AEYE and IDN?
According to the Software industry distribution chart, Health In Tech ranks #1 out of 2247 companies for Debt-to-Equity. This places Health In Tech in the top 0% of its industry — outperforming the majority of peers. The industry median Debt-to-Equity is 0.19. Health In Tech's value of 0.01 is 94.7% below this benchmark. Historically, Health In Tech's own Debt-to-Equity has ranged from 0.01 to 0.34 over the past decade. While the company's 10-year median is 0.01 vs. the industry median of 0.19, Health In Tech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Software company?
The median Debt-to-Equity among Software companies is 0.19, based on 2,247 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Health In Tech's current Debt-to-Equity of 0.01 is 94.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Health In Tech and its competitors. For the Software industry, the median Debt-to-Equity is 0.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health In Tech's current Debt-to-Equity is 0.01, which is near median its own 10-year median of 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health In Tech stock overvalued right now?
Health In Tech (HIT) has a current Debt-to-Equity of 0.01. The current Debt-to-Equity is 0.01, which is near median its 10-year median of 0.01 and 94.7% below the Software industry median of 0.19. Health In Tech's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Health In Tech (HIT), the current Debt-to-Equity is 0.01 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Health In Tech Inc is an AI-enabled insurance technology platform company that offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, it streamlines the underwriting, sales, and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs), and third-party administrators (TPAs). The company's platform serves as a marketplace for brokers, TPAs, MGUs and carriers with self-funded health insurance options for employers. The platform includes functions such as plan customization, stop-loss quoting, underwriting, claims administration, and reporting integration.
19GF Score
Get the complete analysis for HIT
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HIT has been successfully added to your 
